HCL sees opportunities in mid sized, large pharma cos during slowdown phase
Tuesday, May 12, 2009 08:00 IST Our Bureau, Bangalore
Mid sized and large pharma and biotech companies are reorganizing to optimize business processes through increased adoption IT solutions. HCL is gearing up to maximize its presence in the segment.
